Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SUNSTAR: Abatacept vs Tocilizumab in RA Patients Inadequate Responders to TNFi
NCT03227419Phase 4Unknown
- Sponsor
- Université Catholique de Lille
- Start
- Jan 2018
- Primary completion
- Sep 2024
- Modality
- Antibody Conjugates, Engineered Antibody Formats, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of tocilizumab, abatacept in rheumatoid arthritis (RA), sponsored by Université Catholique de Lille. Status: unknown.
02
Drugs
tocilizumababatacept
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT03227419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03227419.